PCM
NH

Prelude Capital Management’s NantHealth, Inc NH Stock Holding History

Prelude Capital Management’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-387
Closed -$18K – 2033
2018
Q1 		$18K Hold
387
– – ﹤0.01% 1279
2017
Q4 		$18K Buy
+387
New +$20.5K ﹤0.01% 1155

Other funds holding NH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prelude Capital Management's NH Position: Q2 2018 in Review

Prelude Capital Management sold out of NantHealth, Inc (NH) in Q2 2018, closing a stake of 387 shares — an estimated $18K sold.

Prelude Capital Management first reported a position in NH in Q4 2017 and held it in 2 quarters. The position peaked at $18K in Q1 2018. 49 funds tracked by Wall St. Rank hold NH as of Q2 2018.

  • Prelude Capital Management reported no remaining NantHealth, Inc position as of Q2 2018 after selling out during the quarter.
  • Prelude Capital Management sold 387 NantHealth, Inc shares in Q2 2018, an estimated $18K.
  • Prelude Capital Management first reported a position in NantHealth, Inc in Q4 2017 and held it in 2 quarters.
  • Prelude Capital Management's NantHealth, Inc position peaked at $18K in Q1 2018.
  • 49 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2018.

Based on Prelude Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.